Quick Order Cart

Cat. No. ARG42649

CBARP Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The CBARP Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in Raji B lymphoblasts, with targeted disruption of CACNB?associated regulatory protein (CBARP). This human Burkitt lymphoma-derived model features EBV positivity and a MYC/IgH translocation, providing a malignant B?cell context for calcium signaling studies. CBARP interacts with voltage?gated calcium channel ?? subunits and AKAP7 to modulate channel trafficking, linking PKA and CaMKII signaling to calcium influx. Disruption of CBARP enables investigators to probe B?cell receptor calcium dynamics, GPCR?cAMP pathway cross?talk, and therapeutic target validation in lymphoma immunology.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    CBARP

    Gene Identifier

    NCBI Gene ID 255057

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CBARP Knockout Raji Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout population derived from the human Raji B lymphocyte cell line, harboring a targeted disruption of the CBARP gene. This loss?of?function tool permits investigation of CBARP?mediated regulation of voltage?gated calcium channel trafficking and activity within a model of malignant B cells.

The Raji line is an Epstein?CBarr virus?positive Burkitt lymphoma?derived B lymphoblast that carries a t(8;14) MYC/immunoglobulin heavy?chain translocation. It exhibits germinal center B?cell characteristics, expresses functional B?cell receptors, and is capable of antibody production, making it a well?established system for immunological and hematological malignancy research.

CBARP (CACNB?associated regulatory protein) serves as an adaptor that binds to voltage?gated calcium channel ?? subunits (CACNB1?C4) and couples them to the A?kinase anchoring protein AKAP7, thereby localizing PKA to the channel complex. It is regulated by cAMP?dependent PKA, Ca2+/calmodulin?dependent protein kinase II (CaMKII), and ???adrenergic agonists. CBARP modulates the trafficking and surface expression of L?type (CaV1.2, encoded by CACNA1C) and N?type (CaV2.2) channels, thus controlling calcium influx that activates downstream effectors such as calcineurin and CaMKII. In the canonical signaling cascade, ADRB2 stimulation activates GNAS/adenylyl cyclase, generating cAMP that releases PKA catalytic subunits (PRKACA) to phosphorylate CBARP?associated targets, integrating GPCR?cAMP?PKA and calcium signaling.

In Raji B lymphocytes, CBARP disruption is predicted to uncouple PKA signaling from voltage?gated calcium entry, altering B?cell receptor?mediated calcium oscillations and downstream activation events. Dysregulated calcium signaling has been implicated in B?cell lymphoma survival and proliferation; therefore, this knockout model enables dissection of how CBARP?dependent channel modulation impacts malignant B?cell physiology and potentially identifies vulnerabilities in calcium?dependent growth pathways.

Researchers can employ calcium imaging with Fluo?4 to monitor real?time cytosolic Ca2+ dynamics and patch?clamp electrophysiology to assess channel currents. Biochemical characterization via western blotting for CACNB3 and Cav subunits, combined with co?immunoprecipitation, permits analysis of channel?complex composition. Functional studies may include GPCR agonist (isoproterenol) stimulation with phospho?PKA substrate analysis, flow cytometric detection of activation markers (CD69, CD86), and apoptosis or viability assays (Annexin V, MTT). The polyclonal population is also suited for immunological synapse calcium dynamics and drug target validation. For further technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)